PREVENTION OF RETROVIRUS-INDUCED ABERRANT CYTOKINE SECRETION, EXCESSIVE LIPID-PEROXIDATION, AND TISSUE VITAMIN-E-DEFICIENCY BY T-CELL RECEPTOR PEPTIDE TREATMENTS IN C57BL 6 MICE/
Bl. Liang et al., PREVENTION OF RETROVIRUS-INDUCED ABERRANT CYTOKINE SECRETION, EXCESSIVE LIPID-PEROXIDATION, AND TISSUE VITAMIN-E-DEFICIENCY BY T-CELL RECEPTOR PEPTIDE TREATMENTS IN C57BL 6 MICE/, Proceedings of the Society for Experimental Biology and Medicine, 214(1), 1997, pp. 87-94
To test whether T cell receptor (TCR) peptide treatment can prevent im
mune dysfunction, excessive lipid peroxidation, and malnutrition cause
d by retrovirus infection, female C57BL/6 mice were infected with LP-B
M5 retrovirus, Infection with retrovirus inhibited lymphocyte prolifer
ation, cytokine release T helper 1 cells, stimulated cytokine secretio
n by T helper 2 cells, induced abnormal hepatic and cardiac lipid prof
iles, and produced excessive tissue lipid peroxidation with hepatic an
d cardiac vitamin E deficiency, Two weeks after infection, TCR peptide
s V beta 5.2, V beta 8.1, V beta 8.1 + V beta 5.2, V beta 8.1(N), and
V beta 8.1(C) were injected to the mice at dose of 200 mu g/ mouse. V
beta 8.1 and V beta 5.2 treatments largely maintained lymphocyte proli
feration and IL-2 and lFN-gamma release, and prevented excessive IL-6,
IL-10, and TNF-alpha secretion. Concomitantly, these treatments norma
lized hepatic and cardiac lipid profiles, reduced tissue lipid peroxid
ation, and thereby significantly maintained vitamin E in the liver and
heart, V beta 8.1 segments treatment did not prevent the immune dysfu
nction, abnormal lipid profile and lipid peroxidation, and vitamin E d
eficiency caused by the retrovirus infection, In conclusion, injection
of intact TCR peptides during murine retrovirus infection largely pre
vented immune dysfunction by blocking the excessive stimulation of a T
cell subset caused by retroviral superantigens. It also ameliorated m
alnutrition status by normalizing lipid profile, lipid peroxidation, a
nd vitamin E deficiency, T cell immune dysfunction and its prevention
by TCR peptide treatment is important in the therapy of vitamin 5 defi
ciency induced by retrovirus infection.